Results

Total Results: 32 records

Showing results for "end stage renal".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - additional scenarios that drive preventive health efforts across varied organizations, workflows, end … • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … • Depending on the end user that will be interacting with the CDS (as well as the intervention action … Stage Renal Disease X Condition code verificationStatus is ‘confirmed’ clinicalStatus is ‘active … ’ no abatement[x] attributes are present End Stage Renal Disease Encounter X Encounter status
  2. cds.ahrq.gov/sites/default/files/cds/artifact/26/2023_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2023 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … Patient has end-stage renal disease. e. Patient is on another anticoagulant. f. … 19 OR diagnosis of active GI ulcers OR diagnosis of bleeding disorders OR diagnosis of endstage renal disease (ESRD) OR dialysis within the past 7 days OR diagnosis of cirrhosis OR MOST … bleeding OR history of peptic ulcer disease OR diagnosis of bleeding disorders OR diagnosis of renal
  3. cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
    December 01, 2018 - Community Health Information Network (OCHIN) Pilot Project Team • Pilot site leadership and clinician end … Both organizations collaborated on refinements to the CDS during every stage of the partnership to improve … end-of-life care (also described as hospice care and palliative care). … include: depression, anxiety, substance use disorder, suicide attempt, sleep-disordered breathing, renal … of accurate CDS interventions. 15 Enhancements that occurred during this stage
  4. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Patient has end-stage renal disease. e. Patient is on another anticoagulant. f. … Figure 1: CDS Artifact Maturity Process To continue the maturation of this artifact to the structured stage … Diagnosis of GI bleed OR Diagnosis of GI ulcers OR Diagnosis of bleeding disorders OR Diagnosis of renal
  5. cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … additional scenarios that drive preventive health efforts across varied organizations, workflows, end … • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … Impaired renal function may influence statin safety.4 For this reason, evidence of ESRD is listed as
  6. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … additional scenarios that drive preventive health efforts across varied organizations, workflows, end … A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy. f. … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … Impaired renal function may influence statin safety.12 For this reason, evidence of ESRD is listed as
  7. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
    April 01, 2021 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end … Many practices may not be in the habit of testing patients on the younger end of this range, which would … - stage renal disease (ESRD), or who have diabetes and a most recent LDL result <70 mg/dL are excepted—that … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … circ.ahajournals.org/content/129/25_suppl_2/S1) are not implemented in this artifact; nevertheless, end
  8. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
    September 01, 2022 - Many practices may not be in the habit of testing patients on the younger end of this range, which would … disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, or who have end-stagerenal disease (ESRD) are excepted—that is, they are counted in the denominator only if they are also … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … circ.ahajournals.org/content/129/25_suppl_2/S1) are not implemented in this artifact; nevertheless, end
  9. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
    September 01, 2022 - Many practices may not be in the habit of testing patients on the younger end of this range, which would … disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, or who have end-stagerenal disease (ESRD) are excepted—that is, they are counted in the denominator only if they are also … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … circ.ahajournals.org/content/129/25_suppl_2/S1) are not implemented in this artifact; nevertheless, end
  10. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact_Updated%20Nov%202019.pdf
    November 01, 2019 - Practically, many practices may not be in the habit of testing patients on the younger end of this range … medications, who are receiving palliative care, who have hepatic disease or insufficiency, who have end-stagerenal disease, and whose most recent LDL result is <70 mg/dL are excepted—that is, they are counted … Value sets needed to be established for computable definitions of ASCVD, end-stage renal disease, hepatic … Depending on the end user that will be interacting with the CDS as well as the intervention action that
  11. cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2023 - Many practices may not be in the habit of testing patients on the younger end of this range, which would … disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, or who have end-stagerenal disease (ESRD) are excepted—that is, they are counted in the denominator only if they are also … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … circ.ahajournals.org/content/129/25_suppl_2/S1) are not implemented in this artifact; nevertheless, end
  12. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - Report with the artifact to describe CDS integration, testing, and implementation details, along with end-user … disease or hepatic disease or insufficiency, who have statin-associated muscle symptoms, who have end-stagerenal disease (ESRD), or who have documentation of a medical reason for not being prescribed statin … • Depending on the end user who will be interacting with the CDS (as well as the intervention action … different strength statin for different patient groups are not implemented in this artifact; nevertheless, end

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: